Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease. - Bradshaw, Daniel; Abramowicz, Iga; Bremner, Stephen; Verma, Sumita; Gilleece, Yvonne; Kirk, Sarah; Nelson, Mark; Housman, Rosalie; Miras, Helena; Orkin, Chloe; Fox, Ashini; Curnock, Michael; et al. (PLoS ONE, 2023)